Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer
Yuejie
Zhu
a,
Xiang
Li
a,
Qi
Zhang
a,
Xiantao
Yang
ab,
Xudong
Sun
a,
Yi
Pan
a,
Xia
Yuan
a,
Yuan
Ma
a,
Bo
Xu
a and
Zhenjun
Yang
*a
aState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. E-mail: yangzj@bjmu.edu.cn; Fax: +86 10 82802503; Tel: +86 10 82802503
bSchool of Pharmacy, Chengdu Medical College, 783 Xindu Avenue, Xindu District, Chengdu, 610500, China
First published on 15th April 2024
Abstract
Correction for ‘Aptamer AS1411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer’ by Yuejie Zhu et al., RSC Med. Chem., 2024, https://doi.org/10.1039/d3md00752a.
The authors regret that the title of their manuscript showed an error. “AS411” should be “AS1411”. The correct title is shown above.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2024 |